Table 2 Clinical parameters of NHANES III Participants Aged 60 and over by NAFLD status, U.S. 1988–1994
|  | Aged 60–74 (n = 2095) | Aged 75 and over (n = 1176) | All (n = 3271) | ||
|---|---|---|---|---|---|
NAFLD | No NAFLD | NAFLD | No NAFLD | ||
AST (IU/L), mean (SE) | 21.75 (0.27)* | 19.98 (0.17) | 21.28 (0.47) | 20.51 (0.17) | 20.73 (0.13) |
ALT (IU/L), mean (SE) | 17.83 (0.39)*†| 12.43 (0.25) | 14.26 (0.61)* | 10.68 (0.20) | 13.89 (0.29) |
Albumin (g/dL), mean (SE) | 4.04 (0.02) | 4.02 (0.02) | 3.99 (0.01) | 3.98 (0.01) | 4.02 (0.01) |
Platelet (1000 cell/uL), mean (SE) | 259.01 (3.75) | 261.57 (2.90) | 252.90 (2.84) | 247.93 (3.39) | 257.51 (2.23) |
ASCVD, mean (SE) | 20.80 (0.32)*†| 14.42 (0.26) | 44.39 (0.63)* | 40.95 (0.66) | 24.21 (0.42) |
eGFR, mean (SE) | 76.20 (0.38)*†| 78.40 (0.48) | 61.34 (0.96)* | 65.79 (0.70) | 73.67 (0.33) |
HOMA, mean (SE) | 7.36 (0.36)* | 1.79 (0.03) | 7.24 (0.57)* | 1.80 (0.02) | 4.01 (0.14) |
NFS, mean (SE) | −0.64 (0.06)*†| −1.06 (0.05) | 0.07 (0.06) | −0.05 (0.05) | −0.64 (0.04) |
NFS, % | |||||
 > 0.676 | 13.92 (1.08)*†| 6.13 (0.80) | 31.54 (2.05)* | 23.49 (1.21) | 14.20 (0.84) |
 0.676 - -1.455 | 60.65 (1.86) | 59.50 (1.29) | 60.27 (2.14)* | 65.78 (1.73) | 61.00 (0.88) |
 < −1.455 | 25.43 (2.07)*†| 34.38 (1.47) | 8.19 (1.11) | 10.74 (1.20) | 24.80 (1.01) |
APRI, mean (SE) | 0.28 (0.01)* | 0.25 (0.00) | 0.28 (0.01) | 0.27 (0.00) | 0.27 (0.00) |
APRI (> 0.7) % | 2.05 (0.36)* | 0.56 (0.15) | 1.77 (0.76) | 1.08 (0.25) | 1.22 (0.14) |